Mold Illness and CIRS: The Evidence Behind Chronic Inflammatory Response

A Diagnosis That Divides Physicians and Patients

Chronic Inflammatory Response Syndrome (CIRS) is a multi-system illness diagnosis proposed by physician Ritchie Shoemaker in the 1990s and 2000s, attributed primarily to exposure to water-damaged buildings and the biotoxins produced by mold, bacteria, and other organisms in those environments. The diagnosis commands enormous patient communities online and a dedicated ecosystem of testing laboratories and treating clinicians. It also remains outside the mainstream of recognized medical diagnoses: no major medical organization — including the CDC, American Academy of Allergy Asthma and Immunology, or American College of Occupational and Environmental Medicine — has endorsed CIRS as an established clinical entity. Understanding the evidence base, and its gaps, requires separating what is documented about mold health effects from the specific claims attached to the CIRS framework.

The CIRS Theory: Core Claims

Shoemaker's model proposes that a subset of people — estimated at 25% of the population — carry HLA-DR gene variants that prevent their immune systems from properly tagging and clearing biotoxins produced in water-damaged buildings. Unable to eliminate these toxins, this population develops a cascade of immune dysregulation, hormonal disruption, and neurological damage. The theory extends beyond mold to include toxins from cyanobacteria (blue-green algae), dinoflagellates, Borrelia (Lyme disease), and pfiesteria.

• HLA-DR genetic susceptibility: CIRS theory proposes that specific HLA-DR subtypes confer inability to clear biotoxins; approximately 25% of the population is said to carry susceptible variants
• MMP-9 elevation: Matrix metalloproteinase-9, a protease involved in inflammation, is elevated in some water-damaged building patients in observational studies; proposed as a biomarker
• VCS (Visual Contrast Sensitivity) testing: A computerized vision test measuring contrast discrimination is used as a CIRS screening tool; proponents argue biotoxin illness impairs VCS; critics note the test has not been validated for this purpose in blinded trials
• Hormonal disruptions: The framework proposes cascading hormonal dysregulation including low MSH (melanocyte-stimulating hormone), low VIP (vasoactive intestinal peptide), and ACTH abnormalities

What Mainstream Medicine Accepts vs. What Remains Contested

The evidence picture is not all-or-nothing. Documented mold health effects and the specific CIRS framework occupy different positions on the evidence spectrum.

The Patient Experience and Why It Matters

People diagnosed with CIRS typically report devastating symptom burdens: profound fatigue, cognitive difficulties, musculoskeletal pain, headaches, and sensitivity to light and sound. These experiences are real. The central dispute is not whether patients are suffering but whether CIRS's proposed mechanism correctly explains their symptoms and whether the Shoemaker treatment protocol is the appropriate response.

• The symptom constellation attributed to CIRS overlaps substantially with fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), mast cell activation syndrome (MCAS), and functional somatic disorders — all of which have their own evidence bases and treatment approaches
• Some patients reporting CIRS-type symptoms in water-damaged buildings improve after remediation and building avoidance; whether this validates the CIRS mechanism or simply reflects removal of known irritants (allergens, endotoxins, volatile organic compounds) is unclear from available data
• Nocebo effects — physical symptoms triggered by the expectation of harm — have been documented in environmental illness contexts and are not dismissible as patient malingering; they reflect real neurobiological processes

The Shoemaker Protocol: What It Involves and Costs

Treatment under the Shoemaker CIRS protocol is elaborate, sequential, and expensive, as it is largely not covered by mainstream health insurers who do not recognize CIRS as a diagnostic category.

What Responsible Environmental Medicine Recommends

The American College of Occupational and Environmental Medicine (ACOEM) published a comprehensive evidence review in 2011 examining adverse health effects of damp indoor environments. Its conclusions: water-damaged buildings are associated with upper and lower respiratory symptoms, asthma exacerbation, and possibly hypersensitivity pneumonitis. The review found insufficient evidence to support unique diagnostic entities (including CIRS) beyond known immune-mediated mechanisms. Remediation and avoidance remain the recommended interventions for symptomatic individuals in water-damaged buildings — the same first step that CIRS proponents recommend, even if the proposed downstream mechanisms differ fundamentally from what mainstream evidence supports. Patients deserve both validation of their suffering and honest assessment of what treatments the evidence can actually support.

This article is for informational purposes only. Consult a qualified healthcare professional before making medical decisions.